Literature DB >> 10716683

Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure.

R Jalan1, P C Hayes.   

Abstract

BACKGROUND AND AIMS: To test the contribution of portal pressure gradient (PPG) and neurohumoral factors to sodium handling in cirrhotic patients without ascites, by comparing preascitic cirrhotic patients with patients with transjugular intrahepatic portosystemic stent shunt (TIPSS) and previous ascites. PATIENTS: Ten patients with TIPSS and 10 preascitic cirrhotic patients.
METHODS: Changes in glomerular filtration, renal plasma flow, urinary sodium excretion (U(Na)V), and neurohumoral factors were measured before and for two hours after infusion of one litre of 0. 9% saline over one hour.
RESULTS: Glomerular filtration rate and renal plasma flow were significantly higher in patients with TIPSS compared with preascitic cirrhotic patients. Following saline infusion both parameters increased significantly; this increase was significantly greater in patients with TIPSS. U(Na)V increased significantly in both groups following saline infusion. The increase in U(Na)V was significantly greater in the TIPSS group. Plasma renin activity and angiotensin II decreased significantly in both groups. Basal U(Na)V was independently correlated with angiotensin II concentration and PPG and the change in U(Na)V correlated with the PPG.
CONCLUSIONS: Results suggest that patients with advanced liver disease and low portal pressure handle sodium as well as patients with compensated liver disease and high portal pressure. These results are consistent with the notion that in addition to peripheral vasodilatation and severity of liver disease, the severity of portal hypertension contributes to the abnormalities of sodium retention in cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10716683      PMCID: PMC1727895          DOI: 10.1136/gut.46.4.527

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  40 in total

1.  Circulatory changes in chronic liver disease.

Authors:  J F MURRAY; A M DAWSON; S SHERLOCK
Journal:  Am J Med       Date:  1958-03       Impact factor: 4.965

2.  Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters.

Authors:  J Quiroga; B Sangro; M Núñez; I Bilbao; J Longo; L García-Villarreal; J M Zozaya; M Betés; J I Herrero; J Prieto
Journal:  Hepatology       Date:  1995-04       Impact factor: 17.425

3.  Role of vasopressin in abnormal water excretion in cirrhotic patients.

Authors:  D Bichet; V Szatalowicz; C Chaimovitz; R W Schrier
Journal:  Ann Intern Med       Date:  1982-04       Impact factor: 25.391

4.  Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites.

Authors:  A L Gerbes; V Gülberg; T Waggershauser; J Holl; M Reiser
Journal:  Hepatology       Date:  1998-09       Impact factor: 17.425

5.  Systemic hypotension and diuresis by L-arginine in cirrhotic patients with ascites: role of nitric oxide.

Authors:  K Tajiri; H Miyakawa; N Izumi; F Marumo; C Sato
Journal:  Hepatology       Date:  1995-11       Impact factor: 17.425

6.  Effective plasma volume in cirrhosis with ascites. Evidence that a decreased value does not account for renal sodium retention, a sponteneous reduction in glomerular filtration rate (GFR), and a fall in GFR during drug-induced diuresis.

Authors:  F L Lieberman; S Ito; T B Reynolds
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

7.  Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites.

Authors:  V Arroyo; J Bosch; M Mauri; F Ribera; F Navarro-López; J Rodés
Journal:  Eur J Clin Invest       Date:  1981-06       Impact factor: 4.686

8.  Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure.

Authors:  R J Cody; G J Haas; P F Binkley; Q Capers; R Kelley
Journal:  Circulation       Date:  1992-02       Impact factor: 29.690

9.  Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis.

Authors:  D G Bichet; V J Van Putten; R W Schrier
Journal:  N Engl J Med       Date:  1982-12-16       Impact factor: 91.245

10.  Natriuretic effect of an adenosine-1 receptor antagonist in cirrhotic patients with ascites.

Authors:  A J Stanley; E H Forrest; K Dabos; I A Bouchier; P C Hayes
Journal:  Gastroenterology       Date:  1998-08       Impact factor: 22.682

View more
  6 in total

1.  Does angiotensin II type 1 receptor blockade offer a clinical advantage to cirrhotics with ascites?

Authors:  Hiroshi Fukui
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

Review 2.  Pathophysiology of portal hypertension and its clinical links.

Authors:  Yeon Seok Seo; Vijay H Shah
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

3.  Clinical analysis of surgical treatment of portal hypertension.

Authors:  Xin-Bao Xu; Jing-Xiu Cai; Xi-Sheng Leng; Jia-Hong Dong; Ji-Ye Zhu; Zhen-Ping He; Fu-Shun Wang; Ji-Run Peng; Ben-Li Han; Ru-Yu Du
Journal:  World J Gastroenterol       Date:  2005-08-07       Impact factor: 5.742

4.  Guidelines on the management of ascites in cirrhosis.

Authors:  K P Moore; G P Aithal
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

5.  Enhanced renal ammonia excretion following volume expansion in patients with well compensated cirrhosis of the liver.

Authors:  R Jalan; D Kapoor
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

6.  Sodium handling is associated with liver function impairment and renin-aldosterone axis activity in patients with preascitic cirrhosis without hyponatremia.

Authors:  Dimitris Tzamouranis; Alexandra Alexopoulou; Spyros P Dourakis; George S Stergiou
Journal:  Ann Gastroenterol       Date:  2012
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.